0001628280-23-032116.txt : 20230912 0001628280-23-032116.hdr.sgml : 20230912 20230912174129 ACCESSION NUMBER: 0001628280-23-032116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230908 FILED AS OF DATE: 20230912 DATE AS OF CHANGE: 20230912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christensen Jamie CENTRAL INDEX KEY: 0001599324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 231251103 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS, INC. STREET 2: 9393 TOWNE CENTRE DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wk-form4_1694554880.xml FORM 4 X0508 4 2023-09-08 0 0001576263 Mirati Therapeutics, Inc. MRTX 0001599324 Christensen Jamie C/O MIRATI THERAPEUTICS, INC. 3545 CRAY COURT SAN DIEGO CA 92121 0 1 0 0 EVP & Chief Scientific Officer 0 Common Stock 2023-09-08 4 S 0 2388 35.63 D 144032 D Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021. /s/ John Moriarty, Attorney-in-Fact 2023-09-12